News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
390,870 Results
Type
Article (24204)
Company Profile (70)
Press Release (366594)
Multimedia
Podcasts (89)
Webinars (13)
Section
Business (132167)
Career Advice (969)
Deals (20682)
Drug Delivery (99)
Drug Development (51410)
Employer Resources (95)
FDA (9019)
Job Trends (8566)
News (200281)
Policy (18624)
Tag
2027 BioCapital Standard (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (4)
Academia (1374)
Academic (1)
Accelerated approval (35)
ADA (21)
Adcomms (17)
Allergies (136)
Alliances (30273)
ALS (122)
Alzheimer's disease (940)
Antibody-drug conjugate (ADC) (247)
Approvals (9421)
Artificial intelligence (405)
ASCO (177)
Autoimmune disease (145)
Automation (31)
Bankruptcy (184)
Best Places to Work (6351)
BIO (37)
Biologics (1)
BIOSECURE Act (11)
Biosimilars (197)
BioSpace Insights (95)
Biotechnology (32)
Bladder cancer (79)
Brain cancer (50)
Breast cancer (374)
Cancer (2943)
Cardiovascular disease (329)
Career advice (851)
Career pathing (31)
CAR-T (137)
CDC (35)
Celiac Disease (2)
Cell therapy (391)
Cervical cancer (30)
Clinical research (45731)
Collaboration (1292)
Commercialization (3)
Company closure (2)
Compensation (480)
Complete response letters (61)
COVID-19 (1601)
CRISPR (73)
C-suite (851)
Cystic fibrosis (80)
Data (4571)
Decentralized trials (1)
Denatured (27)
Depression (100)
Dermatology (53)
Diabetes (353)
Diagnostics (2870)
Digital health (24)
Diversity (8)
Diversity, equity & inclusion (29)
Drug discovery (229)
Drug pricing (144)
Drug shortages (28)
Duchenne muscular dystrophy (161)
Earnings (43729)
Editorial (47)
Employer branding (8)
Employer resources (89)
Events (55305)
Executive appointments (791)
FDA (11194)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (959)
Gene editing (127)
Generative AI (40)
Gene therapy (369)
GLP-1 (733)
Government (2311)
Grass and pollen (6)
Guidances (244)
Healthcare (8034)
Hematology (111)
HIV (62)
Huntington's disease (31)
IgA nephropathy (73)
Immunology and inflammation (158)
Immuno-oncology (52)
Indications (142)
Infectious disease (1798)
Inflammatory bowel disease (137)
Inflation Reduction Act (9)
Influenza (69)
Intellectual property (166)
Interviews (151)
IPO (8222)
IRA (40)
Job creations (2428)
Job search strategy (733)
JPM (37)
Kidney cancer (17)
Labor market (64)
Layoffs (296)
Leadership (26)
Legal (4412)
Licensing (4)
Liver cancer (49)
Longevity (16)
Lung cancer (359)
Lymphoma (256)
Machine learning (27)
Management (35)
Manufacturing (743)
Marketing (7)
MASH (142)
Medical affairs (1)
Medical device (4213)
Medtech (4288)
Mergers & acquisitions (13225)
Metabolic disorders (964)
mRNA (110)
Multiple sclerosis (135)
NASH (20)
Neurodegenerative disease (204)
Neuropsychiatric disorders (61)
Neuroscience (1844)
Neurotech (1)
NextGen: Class of 2026 (3119)
Non-profit (2015)
Now hiring (29)
Obesity (453)
Opinion (195)
Ovarian cancer (116)
Pain (178)
Pancreatic cancer (127)
Parkinson's disease (195)
Partnered (22)
Patents (323)
Patient recruitment (343)
Peanut (32)
People (39442)
Pharmaceutical (36)
Pharmacy benefit managers (24)
Phase 1 (11835)
Phase 2 (19737)
Phase 3 (17251)
Pipeline (5533)
Policy (223)
Postmarket research (1827)
Preclinical (4761)
Press Release (48)
Prostate cancer (207)
Psychedelics (40)
Radiopharmaceuticals (210)
Rare diseases (722)
Real estate (3429)
Recruiting (37)
Regulatory (15232)
Reports (24)
Research institute (1324)
Resumes & cover letters (124)
Rett syndrome (16)
RNA editing (11)
RSV (50)
Schizophrenia (110)
Series A (185)
Series B (121)
Service/supplier (1)
Sickle cell disease (79)
Special edition (12)
Spinal muscular atrophy (119)
Sponsored (18)
Startups (2291)
State (2)
Stomach cancer (9)
Supply chain (80)
Tariffs (77)
The Weekly (60)
Vaccines (644)
Venture capital (71)
Weight loss (289)
Women's health (71)
Worklife (11)
Date
Today (86)
Last 7 days (307)
Last 30 days (1111)
Last 365 days (15087)
2026 (9119)
2025 (15166)
2024 (17688)
2023 (20119)
2022 (27256)
2021 (29136)
2020 (27978)
2019 (24068)
2018 (18620)
2017 (19169)
2016 (18475)
2015 (21954)
2014 (16770)
2013 (13804)
2012 (14966)
2011 (15682)
2010 (14069)
Location
Africa (479)
Alabama (32)
Alaska (4)
Arizona (149)
Arkansas (5)
Asia (28049)
Australia (4220)
California (6094)
Canada (2272)
China (1034)
Colorado (246)
Connecticut (233)
Delaware (248)
Europe (61022)
Florida (1119)
Georgia (202)
Hawaii (2)
Idaho (26)
Illinois (679)
India (95)
Indiana (412)
Iowa (3)
Japan (468)
Kansas (94)
Kentucky (30)
Louisiana (23)
Maine (15)
Maryland (812)
Massachusetts (4645)
Michigan (108)
Minnesota (356)
Mississippi (1)
Missouri (69)
Montana (12)
Nebraska (13)
Nevada (50)
New Hampshire (19)
New Jersey (2263)
New Mexico (14)
New York (1817)
North Carolina (980)
North Dakota (2)
Northern California (2962)
Ohio (184)
Oklahoma (7)
Oregon (19)
Pennsylvania (1315)
Puerto Rico (20)
Rhode Island (20)
South America (719)
South Carolina (22)
Southern California (2619)
Tennessee (99)
Texas (877)
United States (23440)
Utah (126)
Vermont (1)
Virginia (246)
Washington D.C. (48)
Washington State (507)
West Virginia (1)
Wisconsin (75)
Wyoming (2)
390,870 Results for "cspc pharmaceutical group".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
China
AstraZeneca taps China’s CSPC again, betting up to $1.77B to target kidney diseases
AstraZeneca and CSPC Pharmaceutical Group have already inked two other agreements this year, including an obesity-focused deal in January and one focused on chronic diseases in June.
July 2, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Madrigal Pharmaceuticals Enters into Exclusive Global License Agreement for Oral GLP-1 Receptor Agonist with CSPC Pharmaceutical Group Limited
July 30, 2025
·
7 min read
Obesity
AstraZeneca’s China Trip Yields CSPC Obesity Deal Worth $1.2B Upfront
The pact, which could see AstraZeneca ultimately put out $18.5 billion in milestones and sales-based payments, is centered on SYH2082, a long-acting dual agonist of the GLP-1 and GIP receptors.
January 30, 2026
·
2 min read
·
Tristan Manalac
Artificial intelligence
AstraZeneca Makes $5.3B AI Bet With China’s CSPC for Chronic Disease Pills
Friday’s deal with CSPC fits neatly within AstraZeneca’s business development strategy of upping investments in AI and in China.
June 13, 2025
·
2 min read
·
Tristan Manalac
Press Releases
GNI Group Completes Acquisition of AYUMI Pharmaceutical
July 1, 2026
·
5 min read
MASH
Madrigal Makes Potential $2B+ Bet for CSPC’s GLP-1 Pill
Madrigal will study SYH2086 in combination with Rezdiffra for metabolic dysfunction-associated steatohepatitis, aiming for clinical trials in early 2026.
July 30, 2025
·
2 min read
·
Tristan Manalac
Press Releases
ACG appoints Lalit Kasliwal as Group Chief Financial Officer
New Group Chief Financial Officer to support next phase of international growth
July 29, 2026
·
1 min read
Press Releases
Chiesi Group Completes Acquisition of KalVista Pharmaceuticals
June 11, 2026
·
8 min read
Press Releases
GNI Group to Acquire Ayumi Pharmaceutical Holdings, Expanding Its Position as a Global Biopharmaceutical Company
June 8, 2026
·
4 min read
Artificial intelligence
AstraZeneca Makes Another AI Deal With $555M Algen Alliance
AstraZeneca has invested heavily in AI, primarily through collaborations, including an up to $5.3 billion partnership with China’s CSPC Pharmaceutical in June.
October 6, 2025
·
2 min read
·
Tristan Manalac
1 of 39,087
Next
